Stock Analysis

KRX Growth Stocks With High Insider Ownership For August 2024

KOSDAQ:A137400
Source: Shutterstock

In the last week, the South Korean market has stayed flat, but it is up 3.4% over the past year with earnings forecasted to grow by 29% annually. In this environment, growth companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those who know the business best.

Top 10 Growth Companies With High Insider Ownership In South Korea

NameInsider OwnershipEarnings Growth
People & Technology (KOSDAQ:A137400)16.5%35%
ALTEOGEN (KOSDAQ:A196170)26.6%72.9%
Fine M-TecLTD (KOSDAQ:A441270)17.1%36.4%
Global Tax Free (KOSDAQ:A204620)18.1%72.4%
Seojin SystemLtd (KOSDAQ:A178320)29.6%58.7%
Vuno (KOSDAQ:A338220)19.5%105%
INTEKPLUS (KOSDAQ:A064290)16.3%77.4%
UTI (KOSDAQ:A179900)33.1%122.7%
HANA Micron (KOSDAQ:A067310)20%97.4%
Techwing (KOSDAQ:A089030)18.7%77.8%

Click here to see the full list of 81 stocks from our Fast Growing KRX Companies With High Insider Ownership screener.

Let's review some notable picks from our screened stocks.

Daejoo Electronic Materials (KOSDAQ:A078600)

Simply Wall St Growth Rating: ★★★★★★

Overview: Daejoo Electronic Materials Co., Ltd. develops and sells electronic materials across South Korea, China, Taiwan, the United States, Europe, and Southeast Asia with a market cap of ₩1.74 trillion.

Operations: The company generates revenue of ₩193.79 billion from the development, production, and sale of electrical and electronic components.

Insider Ownership: 28.9%

Return On Equity Forecast: 25% (2027 estimate)

Daejoo Electronic Materials, with substantial insider ownership, has shown strong growth potential. Recent private placements totaling KRW 61 billion indicate significant investor confidence and provide capital for expansion. The company reported impressive Q1 2024 results with sales of KRW 46.30 million and net income of KRW 5.65 million, reversing a prior loss. Earnings are forecast to grow at an annual rate of 55.82%, outpacing the market's average growth rate, though the stock has experienced high volatility recently.

KOSDAQ:A078600 Earnings and Revenue Growth as at Aug 2024
KOSDAQ:A078600 Earnings and Revenue Growth as at Aug 2024

People & Technology (KOSDAQ:A137400)

Simply Wall St Growth Rating: ★★★★★★

Overview: People & Technology Inc. provides coating, calendaring, slitting, automation, and other machinery services with a market cap of ₩1.33 trillion.

Operations: People & Technology Inc. generates revenue primarily from its Machinery & Industrial Equipment segment, amounting to ₩645.76 billion.

Insider Ownership: 16.5%

Return On Equity Forecast: 28% (2027 estimate)

People & Technology, with high insider ownership, is forecast to achieve significant earnings growth of 35% per year over the next three years, surpassing the South Korean market average. Revenue is also expected to grow at 36.5% annually, outpacing market projections. Despite trading at a substantial discount (63.6%) below its estimated fair value and having experienced a 31.4% earnings increase last year, the stock has shown high volatility recently and shareholders faced dilution in the past year.

KOSDAQ:A137400 Earnings and Revenue Growth as at Aug 2024
KOSDAQ:A137400 Earnings and Revenue Growth as at Aug 2024

ALTEOGEN (KOSDAQ:A196170)

Simply Wall St Growth Rating: ★★★★★★

Overview: ALTEOGEN Inc. is a biotechnology company specializing in the development of long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars, with a market cap of ₩16.73 billion.

Operations: The company's revenue segments include long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.

Insider Ownership: 26.6%

Return On Equity Forecast: 45% (2027 estimate)

ALTEOGEN, with high insider ownership, is forecast to achieve substantial earnings growth of 72.9% annually over the next three years, significantly outpacing the South Korean market average. Despite trading at a significant discount (72.2%) below its estimated fair value and having become profitable this year, the stock has shown high volatility recently and shareholders faced dilution in the past year. The recent MFDS approval of Tergase® marks a key milestone for ALTEOGEN's commercial expansion.

KOSDAQ:A196170 Earnings and Revenue Growth as at Aug 2024
KOSDAQ:A196170 Earnings and Revenue Growth as at Aug 2024

Turning Ideas Into Actions

Looking For Alternative Opportunities?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com